With the conservative pharma industry showing signs that it can adapt under pressure, clinical trials are finally being pushed into the 21st Century. Teckro CEO Gary Hughes explains how COVID-19 is reshaping the industry and why sponsors can no longer ignore the advantages of modern technology.